Description  Claims  Drawing  Cited references 

US2012142726A1   [0004] 
WO2013062947A1   [0004] 
US5492896A   [0004] 

The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo   [0002]  [0002] 
Therapeutic anti-inflammatory potential of formyl peptide receptor agonists   [0002] 
Anti-inflammatory role of the murine formyl-peptide receptor 2: Ligand-specific effects on leukocyte responses and experimental inflammation   [0002] 
FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis   [0003] 
Lipoxin A4 redistributes Mysoin IIA and Cdc42 in macrophages: Implications for phagocytosis of apoptotic leukocytes   [0003] 
Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways   [0003] 
Molecular mechanisms of topical anti-inflammatory effects of lipoxin A(4) in endotoxin-induced uveitis   [0003] 
A role for the mouse 12/15-lipoxygenase pathways in promoting epithelial wound healing and host defense   [0003] 
Endogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury   [0003] 
xins in the eye and their role in wound healing   [0003]